InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,187.70
(
0.13%
)
US TECH 100
17,617.63
(
0.04%
)
Dow Jones
38,884.26
(
0.08%
)
Brent Oil
82.85
(
-0.02%
)
Bitcoin
62,400.02
(
0.11%
)
Post# of 438
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DanWebzster

Send PM Follow Ignore
Followers 10
Posts 1060
Boards Moderated 2
Alias Born 09/04/2000

DanWebzster

Member Level

Re: DanWebzster post# 249

Monday, 07/16/2018 11:37:40 AM

Monday, July 16, 2018 11:37:40 AM

Post# of 438
IOVA is the old LBIO

Tumor Infiltrating Lymphocytes ( TILs ) is the platform upon which its deep pipeline is based.

TILs are isolated from a patient's tumor following resection and expanded in vitro away from the cancer's immune suppressing effects.

IOVA has 10 Ph2 programs and 2 Ph1 programs.

Its lead program received Orphan Drug designation for the treatment of Cervical Cancer

The rise of neoantigens may render this platform relatively useless.

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up